Goethe University
Clinical trials sponsored by Goethe University, explained in plain language.
-
New immune therapy duo battles Tough-to-Treat kidney cancer
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) works better than standard treatments for people with a specific, hard-to-treat type of advanced kidney cancer that has spread. It involved 316 adults with previously untreated, advanced…
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Gentler combo therapy tested to fight leukemia in older patients
Disease control CompletedThis study tested a new treatment plan for older adults (55-75) newly diagnosed with a fast-growing blood cancer called B-cell acute lymphoblastic leukemia (ALL). The goal was to see if using a lower dose of standard chemotherapy, followed by an immunotherapy drug called blinatum…
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Major trial tests tailored, intensive therapies to fight aggressive blood cancers
Disease control CompletedThis large study aimed to find the best treatment plans for adults newly diagnosed with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. It tested personalized, intensive chemotherapy approaches, including a specific drug (nelarabine) for a certain type of ALL, and e…
Phase: PHASE3 • Sponsor: Goethe University • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC